Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Volitionrx Ltd

(AMEX: VNRX)
Add to Portfolio
+0.16 (+3.32%)
as of Feb 20, 2020

Last 4.98
Change +0.16 (+3.32%)
Open 4.80
Prev. Close 4.82
Today's Range
4.80
5.00
52wk Range
2.65
6.84
Volume 139,122
Avg Volume 82,151
Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances

Perfomance Comparison

Name Today 3-Month 1-Year
VNRX +3.32% +7.79% +71.13%
DJIA -0.44% +4.30% +12.58%
S&P 500 -0.38% +7.23% +21.13%

Key Statistics

Annual EPS -0.44
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 200,670
Weighted Alpha +59.29
Standard Deviation +0.84
Profit Margin N/A
Beta 1.67

Growth Rates

YTD +5.06%
1-Year +70.32%
3-Year +10.55%
5-Year +17.27%

Opinion

Sell Hold Buy

Recent Headlines

VolitionRx Limited Announces Full Fiscal Year 2019

PR Newswire via COMTEX - 04:10PM EST
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year ended December 31, 2019. Volition management will host a conference call tomorrow, February 21,(full story)
VNRX: 4.98 (+0.16)

VolitionRx Limited Schedules Full Year 2019 Earnings

PR Newswire via COMTEX - Tue Feb 18, 04:10PM EST
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Friday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full y(full story)
VNRX: 4.98 (+0.16)

Volition Unveils Its Epigenetic Toolbox

PR Newswire via COMTEX - Tue Feb 18, 08:30AM EST
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that research on its Nu.Q(TM) Capture program has led to the development of a suite of novel epigenetic tools building on the breakthroughs announced last month(full story)
VNRX: 4.98 (+0.16)